Moneycontrol
Aug 11, 2017 12:16 PM IST | Source: CNBC-TV18

Sun Pharma Q1 profit seen down 44% to Rs 1,144 cr on pricing pressure in US

Operating profit is likely to crash 40 percent to Rs 1,744.5 crore and margin may contract 1,080 basis points to 24.6 percent compared with same quarter last year.

Sun Pharma Q1 profit seen down 44% to Rs 1,144 cr on pricing pressure in US

Healthcare major Sun Pharmaceutical Industries is expected to post weak set of earnings on Friday for the quarter quarter ended June 2017, due to pricing pressure in US (that contributes 45 percent to total revenue), Halol remediation and GST implementation in India (accounted for 26 percent of sales).

Profit is seen falling 44 percent year-on-year to Rs 1,144 crore and revenue may drop 14 percent to Rs 7,096 crore in Q1, according to average of estimates of analysts polled by CNBC-TV18.

Operating profit is likely to crash 40 percent to Rs 1,744.5 crore and margin may contract 1,080 basis points to 24.6 percent compared with same quarter last year.
Sections
Follow us on
Available On